RSS

nanomedicines

Ardena, contract development and manufacturing organisation (CDMO), has acquired a contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines, ChemConnection. more

News

Nanobiotix, a late clinical-stage nanomedicine company, has started a pre-clinical collaboration with the Providence Cancer Institute to study NBTXR3 — a nanoparticle designed for direct injection into cancerous tumours and activation by radiotherapy more

News

Incorporating telehealth solutions into new drug delivery technologies like nanomedicines can potentially give pharmaceuticals the edge they need to win the fight against disease, says Alexander Myskiw, healthcare & life sciences practice, DataArt more

Analysis

A quick review of some recent treatment approvals, clinical studies and general news in curing diseases, affecting patients from top to bottom. more

News

Nanobiotix, a late-stage clinical nanomedicine company, has announced that the Independent Data Monitoring Committee (IDMC) has completed the interim evaluation of the Phase II/III trial results of NBTXR3 in soft tissue sarcoma. more

News

CEA-Leti has announced the creation of the European Nano-Characterisation Laboratory (EU-NCL), funded by the European Union’s Horizon 2020 research and innovation programme. more

News

The collaboration will focus on combining Bind's Accurin technology with Roche’s proprietary therapeutic payloads and targeting ligands. more